Molecular Diagnostic Raw Enzyme Market, By Technology (Enzyme-Linked Immunosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR)), By Enzyme Type, By End-User, By Application, By Component, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4500
|
Published Date
November 2025
|
Pages
389
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Molecular Diagnostic Raw Enzyme Market size was valued at US$ 1,298.56 Million in 2024, expanding at a CAGR of 9.4% from 2025 to 2032.
The Molecular Diagnostic Raw Enzyme Market includes key biological catalysts such as polymerases, ligases, and reverse transcriptases, which play a vital role in molecular testing platforms like PCR, qPCR, and next-generation sequencing. These enzymes enable accurate detection of genetic material and support applications in infectious disease diagnostics, oncology, and genetic screening. The expanding adoption of advanced molecular diagnostics is driving robust enzyme consumption.
The market is also supported by growing government investment. For example, public research funding has spurred development of critical moleculardiagnostic platforms: over US$250 million in public-sector investment went into the early development of the GeneXpert PCR system. PMC In addition, the WHO launched a US$4million catalytic grant fund in February 2024 to support pathogen genomic surveillance in low and middleincome countries, increasing access to molecular diagnostics at the global level. World Health
Still, the market faces headwinds from high manufacturing costs and strict purity standards, which pose challenges to cost-effective scale-up. Nevertheless, rising demand for point-of-care diagnostics and rapid PCR systems is creating opportunities for specialized and engineered enzyme variants. A major trend is the adoption of recombinant, high-fidelity, and thermostable enzymes, which boost sensitivity, speed, and multiplexing capacity—enhancing modern diagnostic workflows.
Molecular Diagnostic Raw Enzyme Market- Market Dynamics
Growing Burden of Cancer and Infectious Diseases
The increasing global prevalence of cancer and infectious diseases is fueling demand for molecular diagnostic raw enzymes. Key enzymes, including polymerases, ligases, and reverse transcriptases, are essential components in assays used for the early detection, monitoring, and management of these conditions. Rapid and accurate molecular diagnostics enable timely interventions, improving patient outcomes and supporting personalized medicine strategies. For instance, in 2024, approximately 2 million new cancer cases are projected to be diagnosed in the United States, while the CDC has reported notable infectious disease outbreaks, including measles, dengue fever, and a Clade I mpox case. These escalating healthcare challenges are driving the adoption of molecular diagnostics, which in turn is increasing demand for high-quality raw enzymes for PCR, sequencing, and other molecular testing applications.
Molecular Diagnostic Raw Enzyme Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Technology, Enzyme Type, End-User, Application, Component, and Region.
The Molecular Diagnostic Raw Enzyme Market is primarily segmented by application into Oncology, Infectious Diseases, Cardiology, and Others. Among these, the infectious disease segment holds a significant share, driven by the increasing need for rapid and accurate pathogen detection. Advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), rely heavily on high-quality raw enzymes to identify pathogens including tuberculosis, HIV, and other viral infections with precision. Key market players are actively expanding this segment through the development of novel enzyme formulations and automated diagnostic platforms. For example, in May 2022, BD launched the fully automated BD COR MX system in the United States, capable of processing up to 1,700 specimens with minimal staff intervention while detecting pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. This innovation underscores the importance of reliable raw
By technology type, the market is categorized into Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), and Others, with the PCR segment representing a critical component due to its role in enabling precise, high-throughput molecular diagnostics. PCR techniques—including quantitative PCR, reverse transcription PCR, inverse PCR, and multiplex PCR—allow simultaneous detection of multiple targets, with real-time PCR being particularly valuable for cancer marker analysis. The growing adoption of high-throughput PCR technologies has increased demand for premium raw enzymes to ensure accurate amplification and reproducible results. For instance, Thermo Fisher Scientific’s QuantStudio Absolute Q AutoRun dPCR Suite (2023) automates laboratory workflows, enhancing efficiency and reducing operational costs, while Roche’s Digital LightCycler System (2022) has advanced cancer detection and biomarker analysis capabilities. These developments highlight the essential role of PCR enzymes in molecular diagnostics across oncology, infectious diseases, and genetic testing.
Molecular Diagnostic Raw Enzyme Market- Geographical Insights
North America is a key revenue-generating region in the Molecular Diagnostic Raw Enzymes Market in 2025, supported by a well-established healthcare infrastructure that facilitates advanced diagnostic testing. The region’s widespread adoption of innovative in-vitro diagnostic (IVD) platforms has driven demand for raw enzymes across multiple diagnostic applications. Additionally, increasing investments in R&D, along with a growing patient population, have further boosted the utilization of molecular diagnostic enzymes, underscoring North America’s critical role in sustaining overall market growth.
Canada Molecular Diagnostic Raw Enzyme Market- Country Insights
The Canada Molecular Diagnostic Raw Enzyme Market is projected to experience significant growth over the forecast period. The increasing prevalence of cancer and other chronic diseases is driving demand for advanced molecular diagnostic solutions that enable early detection and personalized treatment. According to the Canadian Cancer Society, approximately 247,100 Canadians are expected to be diagnosed with cancer in 2024, up from 239,100 cases in 2023, largely due to the country’s aging and expanding population. Additionally, cancer-related deaths are projected to rise from 86,700 in 2023 to 88,100 in 2024, underscoring the urgent need for accurate and timely diagnostic tools. This rising demand is expected to boost the adoption of molecular diagnostic raw enzymes, which serve as essential components in PCR, sequencing, and other diagnostic assays, thereby driving market growth in Canada.
Molecular Diagnostic Raw Enzyme Market- Competitive Landscape:
The Molecular Diagnostic Raw Enzyme Market features a moderately concentrated competitive landscape, with a few leading players driving innovation and market expansion. Key companies, including Thermo Fisher Scientific, Merck KGaA, and New England Biolabs, focus on developing high-performance enzymes with enhanced stability, specificity, and reproducibility for applications such as PCR, NGS, and infectious disease testing. For example, in 2024, Merck KGaA launched an upgraded DNA polymerase enzyme that improved amplification fidelity by 12%, enhancing efficiency in clinical diagnostic laboratories.
Market competition is shaped by growing demand for accurate and reliable enzyme solutions, regulatory compliance requirements, and the increasing adoption of advanced molecular testing technologies. To address evolving diagnostic needs across hospitals, research institutions, and IVD laboratories worldwide, companies are investing in R&D, strategic partnerships, and portfolio diversification.
Recent Developments:
- June 2025: Enzo Biochem, Inc. entered into a definitive merger agreement with Battery Ventures, a global technology investment firm. Through its newly formed entity Bethpage Parent, Inc., Battery Ventures will acquire Enzo for $0.70 per share in cash, valuing the transaction at approximately $37 million. This acquisition may impact the distribution and availability of Enzo’s enzyme assay kits, including those for alkaline phosphatase, lactate dehydrogenase, and glucose oxidase, as well as its broader diagnostics portfolio.
- September 2024: Promega introduced a newly engineered polymerase designed to significantly reduce stuttering in forensic DNA analysis. By minimizing stutter artifacts, the enzyme simplifies the interpretation of mixed DNA samples, enabling forensic scientists to generate more accurate DNA profiles from multiple sources. This innovation represents the first enzyme specifically developed to address one of the most persistent challenges in DNA forensics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- New England Biolabs (NEB)
- QIAGEN
- Bio-Rad Laboratories
- Takara Bio
- Aldevron
- Codexis
- Thermo Fisher Scientific
- Vazyme Biotech
- Qiagen
- Fapon Biotech
- Yeasen Biotechnology
- Amano Enzyme Inc.
- Advanced Enzymes Technologies Ltd.
- Biocatalysts Ltd.
- Enzo Life Sciences
- MP Biomedicals
- BBI Solutions
- EKF Diagnostics
- Medix Biochemica
- Canvax Biotech
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Polymerase Chain Reaction (PCR)
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY ENZYME TYPE- MARKET ANALYSIS, 2019 - 2032
- Polymerase & Transcriptase
- Ribonuclease
- Proteases
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Biotech & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Liver Function Biochemical Diagnosis
- DNA Testing
- Infectious Disease Diagnosis
- Tumor Diagnosis
- Coagulation Diagnosis
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Infectious Diseases
- Cardiology
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Molecular Diagnostic Raw Enzyme Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Molecular Diagnostic Raw Enzyme Market Snippet by Technology
2.1.2. Molecular Diagnostic Raw Enzyme Market Snippet by Enzyme Type
2.1.3. Molecular Diagnostic Raw Enzyme Market Snippet by End-User
2.1.4. Molecular Diagnostic Raw Enzyme Market Snippet by Application
2.1.5. Molecular Diagnostic Raw Enzyme Market Snippet by Component
2.1.6. Molecular Diagnostic Raw Enzyme Market Snippet by Country
2.1.7. Molecular Diagnostic Raw Enzyme Market Snippet by Region
2.2. Competitive Insights
3. Molecular Diagnostic Raw Enzyme Key Market Trends
3.1. Molecular Diagnostic Raw Enzyme Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Molecular Diagnostic Raw Enzyme Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Molecular Diagnostic Raw Enzyme Market Opportunities
3.4. Molecular Diagnostic Raw Enzyme Market Future Trends
4. Molecular Diagnostic Raw Enzyme Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Molecular Diagnostic Raw Enzyme Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Molecular Diagnostic Raw Enzyme Market Landscape
6.1. Molecular Diagnostic Raw Enzyme Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Molecular Diagnostic Raw Enzyme Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
7.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.1.3. Polymerase Chain Reaction (PCR)
7.1.4. Others
8. Molecular Diagnostic Raw Enzyme Market – By Enzyme Type
8.1. Overview
8.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
8.1.2. Polymerase & Transcriptase
8.1.3. Ribonuclease
8.1.4. Proteases
8.1.5. Others
9. Molecular Diagnostic Raw Enzyme Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
9.1.2. Biotech & Pharmaceutical Companies
9.1.3. Hospitals & Diagnostic Laboratories
9.1.4. Others
10. Molecular Diagnostic Raw Enzyme Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Enzyme Type, 2024 & 2032 (%)
10.1.2. Liver Function Biochemical Diagnosis
10.1.3. DNA Testing
10.1.4. Infectious Disease Diagnosis
10.1.5. Tumor Diagnosis
10.1.6. Coagulation Diagnosis
10.1.7. Others
11. Molecular Diagnostic Raw Enzyme Market – By Component
11.1. Overview
11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
11.1.2. Oncology
11.1.3. Infectious Diseases
11.1.4. Cardiology
11.1.5. Others
12. Molecular Diagnostic Raw Enzyme Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Molecular Diagnostic Raw Enzyme Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Enzyme Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Molecular Diagnostic Raw Enzyme Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. New England Biolabs (NEB)
13.2.2. QIAGEN
13.2.3. Bio-Rad Laboratories
13.2.4. Takara Bio
13.2.5. Aldevron
13.2.6. Codexis
13.2.7. Thermo Fisher Scientific
13.2.8. Vazyme Biotech
13.2.9. Qiagen
13.2.10. Fapon Biotech
13.2.11. Yeasen Biotechnology
13.2.12. Amano Enzyme Inc.
13.2.13. Advanced Enzymes Technologies Ltd.
13.2.14. Biocatalysts Ltd.
13.2.15. Enzo Life Sciences
13.2.16. MP Biomedicals
13.2.17. BBI Solutions
13.2.18. EKF Diagnostics
13.2.19. Medix Biochemica
13.2.20. Canvax Biotech
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- New England Biolabs (NEB)
- QIAGEN
- Bio-Rad Laboratories
- Takara Bio
- Aldevron
- Codexis
- Thermo Fisher Scientific
- Vazyme Biotech
- Qiagen
- Fapon Biotech
- Yeasen Biotechnology
- Amano Enzyme Inc.
- Advanced Enzymes Technologies Ltd.
- Biocatalysts Ltd.
- Enzo Life Sciences
- MP Biomedicals
- BBI Solutions
- EKF Diagnostics
- Medix Biochemica
- Canvax Biotech
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Polymerase Chain Reaction (PCR)
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY ENZYME TYPE- MARKET ANALYSIS, 2019 - 2032
- Polymerase & Transcriptase
- Ribonuclease
- Proteases
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Biotech & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Liver Function Biochemical Diagnosis
- DNA Testing
- Infectious Disease Diagnosis
- Tumor Diagnosis
- Coagulation Diagnosis
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Infectious Diseases
- Cardiology
- Others
GLOBAL MOLECULAR DIAGNOSTIC RAW ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
